72152-547 : Zulresso 5 mg/ml Intravenous Injection, Solution


NDC: 72152-547
Labeler: Sage Therapeutics, Inc.
Product Type: Human Prescription Drug
Drug Name:  Zulresso
Dosage Form: Intravenous Injection, Solution
Application #: NDA211371
Rev. Date: 
CSA Schedule: CIV (US) [1]


[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

  • 72152-547-20: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (72152‑547‑20) > 20 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Brexanolone

Dosage Strength:

  • 5 mg/mL

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72152-547 QR Code

< Prev: 72151-602Next: 72153-323 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.